twee euro in een collectebus

Direct marketing, telemarketing and canvassing for new donors

We receive the majority of our income from private individuals: individual donors and contributions of individuals during actions and events. The contribution of bequests to our annual income over the last few years has been 30%.

Next to direct marketing, telemarketing and canvassing for new donors, the DCS’ lottery contributes to our income with a little over 10 million euro.

An increasing source of income are fundraising events organized by private persons/groups like:

  • Alpe d'HuZes: an amazing fundraising event that started in 2006. Inspired by the slogan ’Never, ever quit’ people contribute to the fight against cancer by cycling up the Alpe d’Huez. Alpe d’HuZes is founded on the belief that everybody can attain the greatest possible satisfaction if they put their heart and soul in helping others. The revenues of this event are transferred to the Alpe d’HuZes/Dutch Cancer Society Fund to finance research projects.

  • Ride for the Roses: This cycling tour, a brand of Livestrong, is an annual event organised since 1998. Every year the tour is organised in a different part of the country. Famous Dutch cyclists have participated in this tour. In 15 years the cyclists contributed with 15 million euro to cancer research in the Netherlands.

  • Relay for life (KWF Samenloop): This walking event, a brand of the American Cancer Society, has been introduced in the Netherlands in 2006. This event supports cancer survivors and it’s a fundraising event. Over the last years the number of Relays has increased to more than 30 local events all over the country. 

  • Under the label ‘Standup2 Cancer’ (Sta op tegen kanker), a brand of the Entertainment Industry Foundation, we developed a webbased platform for people who want to raise a profile for their fundraising event for the DCS and inspire others to start their own event. Next to this platform we organized an annual television show in which we ask people to become a donor of the DCS in order to accelerate ground-breaking translational research. The last DCS Standup2 Cancer show was in 2014.